Senescence marker protein-30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 522-532

  Kondo, Yoshitaka ^a   Masutomi, Hirofumi ^a   Noda, Yoshihiro ^a   Ozawa, Yusuke ^b   Takahashi, Keita ^a   Handa, Setsuko ^a   Maruyama, Naoki ^a   Shimizu, Takahiko ^b   Ishigami, Akihito ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ascorbic acid; Non alcoholic fatty liver disease; Reactive oxygen species; SMP30; SOD1

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; FATTY ACID; GLUCOSE; INSULIN; LIVER PROTEIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REGUCALCIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HISTOLOGY; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOPROTEIN SECRETION; LIVER HOMOGENATE; LIVER MICROSOME; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEX DIFFERENCE; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; GENE EXPRESSION;

MUS;

EID: 84902581445     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.05.003     Document Type: Article

References (46)

1. Musso G., Gambino R., Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes. Rev. 2010, 11:430-445.
2. Basaranoglu M., Basaranoglu G., Senturk H. From fatty liver to fibrosis: a tale of "second hit". World J. Gastroenterol. 2013, 19:1158-1165.
3. Novo E., Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008, 1:5.
4. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., Tsubota K. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice. a model of age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11282-11287.
5. Hashizume K., Hirasawa M., Imamura Y., Noda S., Shimizu T., Shinoda K., Kurihara T., Noda K., Ozawa Y., Ishida S., et al. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am. J. Pathol. 2008, 172:1325-1331.
6. Murakami K., Inagaki J., Saito M., Ikeda Y., Tsuda C., Noda Y., Kawakami S., Shirasawa T., Shimizu T. Skin atrophy in cytoplasmic SOD-deficient mice and its complete recovery using a vitamin C derivative. Biochem. Biophys. Res. Commun. 2009, 382:457-461.
7. Nojiri H., Saita Y., Morikawa D., Kobayashi K., Tsuda C., Miyazaki T., Saito M., Marumo K., Yonezawa I., Kaneko K., et al. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J. Bone Miner. Res. 2011, 26:2682-2694.
8. Murakami K., Murata N., Noda Y., Tahara S., Kaneko T., Kinoshita N., Hatsuta H., Murayama S., Barnham K.J., Irie K., et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease. J. Biol. Chem. 2011, 286:44557-44568.
9. Noda Y., Ota K., Shirasawa T., Shimizu T. Copper/zinc superoxide dismutase insufficiency impairs progesterone secretion and fertility in female mice. Biol. Reprod. 2012, 86:1-8.
10. Kojima T., Wakamatsu T.H., Dogru M., Ogawa Y., Igarashi A., Ibrahim O.M., Inaba T., Shimizu T., Noda S., Obata H., et al. Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice. Am. J. Pathol. 2012, 180:1879-1896.
11. Olofsson E.M., Marklund S.L., Behndig A. Enhanced age-related cataract in copper-zinc superoxide dismutase null mice. Clin. Exp. Ophthalmol. 2012, 40:813-820.
12. Elchuri S., Oberley T.D., Qi W., Eisenstein R.S., Jackson Roberts L., Van Remmen H., Epstein C.J., Huang T.T. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005, 24:367-380.
13. Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts L.J., Csete M., et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 2006, 40:1993-2004.
14. Iuchi Y., Okada F., Onuma K., Onoda T., Asao H., Kobayashi M., Fujii J. Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production. Biochem. J. 2007, 402:219-227.
15. Guturu P., Duchini A. Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity. Int. J. Hepatol. 2012, 2012:212865.
16. Fisher E.A. The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways. Biochim. Biophys. Acta 2012, 1821:778-781.
17. Uchiyama S., Shimizu T., Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J. Biol. Chem. 2006, 281:31713-31719.
18. Ishigami A., Maruyama N. Significance of SMP30 in gerontology. Geriatr. Gerontol. Int. 2007, 7:316-325.
19. Maruyama N., Ishigami A., Kondo Y. Pathophysiological significance of senescence marker protein-30. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S88-S98.
20. 2+-pumping activity in Hep G2 cells. Biochem. Biophys. Res. Commun. 1998, 250:374-380.
21. Ishigami A., Fujita T., Handa S., Shirasawa T., Koseki H., Kitamura T., Enomoto N., Sato N., Shimosawa T., Maruyama N. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-α- and Fas-mediated apoptosis. Am. J. Pathol. 2002, 161:1273-1281.
22. Ishigami A., Kondo Y., Nanba R., Ohsawa T., Handa S., Kubo S., Akita M., Maruyama N. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem. Biophys. Res. Commun. 2004, 315:575-580.
23. Kondo Y., Inai Y., Sato Y., Handa S., Kubo S., Shimokado K., Goto S., Nishikimi M., Maruyama N., Ishigami A. Senescence marker protein 30 functions as gluconolactonase in l-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5723-5728.
24. Aizawa S., Senda M., Harada A., Maruyama N., Ishida T., Aigaki T., Ishigami A., Senda T. Structural basis of the γ-lactone-ring formation in ascorbic acid biosynthesis by the senescence marker protein-30/gluconolactonase. PLoS One 2013, 8:e53706.
25. Linster C.L., Van Schaftingen E. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 2007, 274:1-22.
26. Pohanka M., Pejchal J., Snopkova S., Havlickova K., Karasova J.Z., Bostik P., Pikula J. Ascorbic acid: an old player with a broad impact on body physiology including oxidative stress suppression and immunomodulation: a review. Mini Rev. Med. Chem. 2012, 12:35-43.
27. Ishikawa Y., Hashizume K., Kishimoto S., Tezuka Y., Nishigori H., Yamamoto N., Kondo Y., Maruyama N., Ishigami A., Kurosaka D. Effect of vitamin C depletion on UVR-B induced cataract in SMP30/GNL knockout mice. Exp. Eye Res. 2012, 94:85-89.
28. Arai K.Y., Sato Y., Kondo Y., Kudo C., Tsuchiya H., Nomura Y., Ishigami A., Nishiyama T. Effects of vitamin C deficiency on the skin of the senescence marker protein-30 (SMP30) knockout mouse. Biochem. Biophys. Res. Commun. 2009, 385:478-483.
29. Amano A., Tsunoda M., Aigaki T., Maruyama N., Ishigami A. Effect of ascorbic acid deficiency on catecholamine synthesis in adrenal glands of SMP30/GNL knockout mice. Eur. J. Nutr. 2014, 53:177-185.
30. Kashio A., Amano A., Kondo Y., Sakamoto T., Iwamura H., Suzuki M., Ishigami A., Yamasoba T. Effect of vitamin C depletion on age-related hearing loss in SMP30/GNL knockout mice. Biochem. Biophys. Res. Commun. 2009, 390:394-398.
31. Kondo Y., Sasaki T., Sato Y., Amano A., Aizawa S., Iwama M., Handa S., Shimada N., Fukuda M., Akita M., et al. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem. Biophys. Res. Commun. 2008, 377:291-296.
32. Koike K., Kondo Y., Sekiya M., Sato Y., Tobino K., Iwakami S.I., Goto S., Takahashi K., Maruyama N., Seyama K., et al. Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L784-792.
33. Senmaru T., Yamazaki M., Okada H., Asano M., Fukui M., Nakamura N., Obayashi H., Kondo Y., Maruyama N., Ishigami A., et al. Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice. J. Clin. Biochem. Nutr. 2012, 50:114-118.
34. Hasegawa G., Yamasaki M., Kadono M., Tanaka M., Asano M., Senmaru T., Kondo Y., Fukui M., Obayashi H., Maruyama N., et al. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology 2010, 151:529-536.
35. Yamada S., Saitoh S., Machii H., Mizukami H., Hoshino Y., Misaka T., Ishigami A., Takeishi Y. Coronary artery spasm related to thiol oxidation and senescence marker protein-30 in aging. Antioxid. Redox Signal. 2013, 19:1063-1073.
36. Mizukami H., Saitoh S., Machii H., Yamada S., Hoshino Y., Misaka T., Ishigami A., Takeishi Y. Senescence marker protein-30 (SMP30) deficiency impairs myocardium-induced dilation of coronary arterioles associated with reactive oxygen species. Int. J. Mol. Sci. 2013, 14:9408-9423.
37. Kim H.S., Son T.G., Park H.R., Lee Y., Jung Y., Ishigami A., Lee J. Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation. Neurobiol. Aging 2013, 34:1177-1183.
38. Y/-) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet. PLoS One 2013, 8:e65698.
39. Iwama M., Shimokado K., Maruyama N., Ishigami A. Time course of vitamin C distribution and absorption after oral administration in SMP30/GNL knockout mice. Nutrition 2011, 27:471-478.
40. Amano A., Sato Y., Kishimoto Y., Takahashi K., Handa S., Aigaki T., Maruyama N., Ishigami A. Effects of ascorbic acid deficiency on protein and lipid oxidation in livers from SMP30/GNL knockout mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2013, 59:489-495.
41. Andreo U., Elkind J., Blachford C., Cederbaum A.I., Fisher E.A. Role of superoxide radical anion in the mechanism of apoB100 degradation induced by DHA in hepatic cells. FASEB J. 2011, 25:3554-3560.
42. Huynh F.K., Neumann U.H., Wang Y., Rodrigues B., Kieffer T.J., Covey S.D. A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. Hepatology 2013, 57:543-554.
43. Sato Y., Uchiki T., Iwama M., Kishimoto Y., Takahashi R., Ishigami A. Determination of dehydroascorbic acid in mouse tissues and plasma by using tris(2-carboxyethyl)phosphine hydrochloride as reductant in metaphosphoric acid/ethylenediaminetetraacetic acid solution. Biol. Pharm. Bull. 2010, 33:364-369.
44. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
45. Laing S., Wang G., Briazova T., Zhang C., Wang A., Zheng Z., Gow A., Chen A.F., Rajagopalan S., Chen L.C., et al. Airborne particulate matter selectively activates endoplasmic reticulum stress response in the lung and liver tissues. Am. J. Physiol. Cell Physiol. 2010, 299:C736-C749.
46. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.